Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...

A once weekly injection of semaglutide, the main ingredient in Ozempic and Wegovy, may help problem drinkers kick their cravings. In a new study, the drug, known for treating type 2 diabetes and ...

Surgical tweaks for “Ozempic face” are on the rise. The latest report from AAFPRS reveals a 50% increase in facial fat ...

Jeremy Kim was stabbed outside his apartment building near Mainland and Hamilton streets just before 1 a.m. on Friday after a confrontation with two teenagers.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Semaglutide is the active ingredient in diabetes drug Ozempic and obesity medication Wegovy ... Somewhere around 0.3% of doctors have obesity medicine training. And we know that a lot more ...

Ozempic, the blockbuster GLP-1 drug that was ... The clinical study was stopped early after reaching positive endpoints sooner than expected, and no new safety risks were identified in this ...

THESE DRUGS COULD POSSIBLY PREVENT HEART ATTACK AND STROKE. THE RESULTS ARE PROMISING FOR HEART PATIENTS.. THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS ...

The FDA approves Ozempic for the treatment of chronic kidney disease in patients who also have type 2 diabetes. Ozempic and other diabetes drugs known as GLP-1s have become popular and also well ...